(CHF) continues to be a major health problem in our society. Consequently, a great deal of attention is being devoted to elucidating the mechanisms and pathophysiology of heart failure and developing new treatments. Canine models of heart failure have been very useful in this regard because, unlike smaller animal models, they provide hearts of sufficient size to permit detailed evaluation of cardiac mechanics using techniques that have been developed over the past several years. By far, the most commonly used model of heart failure in dogs has been the rapid pacing model. Studies of these animals have provided a wealth of information about changes in various components of the cardiovascular system with the development of heart failure (2, 9, 18, 20, 21). While there are many features of heart failure in these animals that are similar to that in humans, it has been questioned whether the changes in ventricular and myocardial properties themselves are relevant to the most common form of CHF encountered clinically, which is due to ischemic heart disease.
hearts as assessed by the slope (Ees: 2.74 t 0.49 vs. 4.00 t 1.18 mmHg/ml, P < 0.01) and volume axis intercept (Vo: 8.7 t 5.9 vs. 1.0 t 3.2 ml, P < 0.01) of end-systolic pressure-volume relation compared with a group of six normal dogs. The end-diastolic pressure-volume relation of embolized hearts was shifted to the right, indicating a dilation of the LV However, systolic and diastolic stressstrain relationships were similar in the two groups, suggesting that the average myocardial properties of the embolized hearts are similar to those of normal hearts. The relationship between oxygen consumption and pressure-volume area in embolized hearts had smaller intercept (2.98 5 0.44 vs. 3.92 t 0.39 X 10B2 ml 02ebeatt1* 100 g LV1, P < 0.01) compared with the control group, with no change in the slope. These results contrast with previous findings in pacing CHF and serve as an important characterization of ventricular properties in this model of CHF from different etiology.
stress-strain analysis; myocardial oxygen consumption; pressure-volume relationship; maximum elastance; remodeling CHRONIC HEART FAILURE (CHF) continues to be a major health problem in our society. Consequently, a great deal of attention is being devoted to elucidating the mechanisms and pathophysiology of heart failure and developing new treatments. Canine models of heart failure have been very useful in this regard because, unlike smaller animal models, they provide hearts of sufficient size to permit detailed evaluation of cardiac mechanics using techniques that have been developed over the past several years. By far, the most commonly used model of heart failure in dogs has been the rapid pacing model. Studies of these animals have provided a wealth of information about changes in various components of the cardiovascular system with the development of heart failure (2, 9, 18, 20, 21) . While there are many features of heart failure in these animals that are similar to that in humans, it has been questioned whether the changes in ventricular and myocardial properties themselves are relevant to the most common form of CHF encountered clinically, which is due to ischemic heart disease.
An alternate animal model of heart failure is based on repeated coronary microembolization, which causes diffuse, patchy ischemic insults similar to that observed in humans with extensive coronary atherosclerosis. The heart failure in the embolization model is irreversible and generally progressive (16). While several aspects of this model have been studied (7, 10, 14, 15>, a basic characterization of changes in the ventricular and myocardial contractile properties, chamber structural properties (remodeling), and energetic properties of such hearts have not been documented. Therefore, the purpose of this study was to characterize the mechanical pump properties and basic aspects of the energetics of contraction (specifically, the relationship between oxygen consumption and total mechanical work) in hearts after repeated coronary embolizations. After we completed a series of coronary embolizations and documented a sustained decrement in ventricular performance, hearts were isolated and metabolically supported by blood from a second support dog. A balloon placed within the ventricular chamber was used to define chamber diastolic and systolic properties via pressure-volume relations (17). To investigate myocardial properties independent of chamber structural characteristics, end-systolic and end-diastolic stress-strain relations were determined from the measured pressurevolume relations.
METHODS

Heart Failure Model
Nine mongrel dogs were anesthetized (l-2% inhaled isoflurane), and a coronary angiographic catheter was engaged in the left main coronary artery under fluoroscopic guidance via a femoral approach. A pig-tail catheter was inserted via the contralateral femoral artery into the left ventricle (LV) to monitor LV pressure and for ventriculography.
Glass microspheres (90 urn mean diameter, Spheriglass) suspended in contrast medium (-33,000 spheres/ml) were injected into the left anterior and circumflex branches in divided doses until LV end-diastolic pressure reached -20 mmHg. Diuretics, intravenous nitroglycerine, and prolonged periods of intubation were employed when necessary to treat acute heart failure (manifest as excessive rises in LV end-diastolic pressure and decreases in arterial blood pressure). This procedure was repeated in each animal on an average of five (range 3-6) separate occasions over a 9-wk period until persistent global ventricular dysfunction was observed on transthoracic echocardiography (vide infra). Ventriculography was performed at the beginning of each of the subsequent embolization sessions to assess global and regional wall motion; to achieve incremen- which supplied the region with the best wall motion.
Two of the nine dogs that underwent embolization died due to acute heart failure within hours of embolization, and the third dog died unexpectedly 4 days after embolization. All data are from the six surviving animals. On average, a total of 310 5 90 X lo3 microspheres were injected per dog. These dogs were followed for a total period of 286 * 66 days from the first embolization, over which time they developed persistent left ventricular dysfunction.
The progression of left ventricular dysfunction was followed by periodic transthoracic echocardiograms performed in a conscious resting state. Echocardiograms were quantified off-line by determining LV end-systolic and end-diastolic areas (ESA and EDA, respectively) at the midpapillary muscle level in the short-axis view. Fractional area change was defined as 100 X (EDA -ESA)/EDA.
Isolated Heart Preparation
To assess LV systolic and diastolic properties, the hearts of the six embolized animals and the hearts of six body weightmatched controls were studied in a standard isolated heart preparation.
Details of this preparation have been provided previously (4). Briefly, the heart from the dog of interest was excised and metabolically supported by blood provided from a second "support" dog. The femoral arteries of the support dog were cannulated and connected to a perfusion circuit consisting of two peristaltic pumps, a heater, a blood filter, and an air trap. The pressure in the aortic root of the isolated heart, which is the perfusion pressure for coronary flow, was measured and used as the feedback signal for a servo system that regulated the speed of the peristaltic pump and maintained perfusion pressure at -80 mmHg. Blood traveled through the coronary vasculature of the isolated heart and returned to the support dog by gravity. Coronary flow was collected through a wide-bore cannula placed in the right atrium and right ventricle and was measured by an in-line ultrasonic flowmeter (Transonic Systems model Tl08, Ithaca, NY). The difference between arterial and venous oxygen content was measured on-line by a commercially available spectrophotometer (AVOX Syst ems, San Antonio, TX). Oxygen consumption of the whole heart was determined by multiplying coronary flow by the arteriovenous blood oxygen difference. A water-filled balloon was placed within the left ventricle via the mitral valve. The volume of the balloon, and therefore of the ventricle, was controlled by a piston pump servo system. A micromanometer (Millar Instruments model SPC-360, Houston, TX) placed within the balloon was used to measure ventricular pressure. The heart was paced from the LV apex and was constrained to contract isovolumically.
Protocol
After isolation, the heart was allowed to stabilize for -30 min. LV pressure, coronary blood flow, and arteriovenous blood oxygen difference were measured at several different volumes chosen to provide a range of end-diastolic pressures between <O and a minimum of 20 mmHg. The volume steps between different settings were between 5 and 10 ml depending on the size of the individual hearts. At each volume setting, enough time was allowed to attain steady-state conditions as judged from all signals recorded (usually 2-3 min). Upon completion of baseline data acquisition, continuous intracoronary infusion of isoproterenol was initiated to evaluate P-responsiveness.
The rate of isoproterenol administration was adjusted so that peak isovolumic LV pressure (at a volume which provided end-diastolic pressure of -10 mmHg) increased by 20%. The data were acquired digitally at a sampling frequency of 1,000 Hz.
Histology
After completion of the isolated heart study, the heart was fixed in 10% neutral buffered Formalin. At least nine samples were cut from each heart (anterior, posterior, septal samples from the basal, mid, and apical levels of the LV), embedded in paraffin, and sectioned. Masson's trichrome-stained tissue slides were scanned and digitized for image analysis (Polaroid Sprint Slide Scanner;
Power Macintosh 6100). The number of blue pixels in each section of myocardium (corresponding to collagen) was counted and expressed as a percent of the total number of pixels analyzed (Adobe Photoshop; NIH Image).
Data Analysis
Assessment of global mechanics. Systolic properties of the LV chamber were assessed in the isolated hearts by the linear end-systolic pressure-volume relationship (ESPVR)
where P,, is end-systolic pressure, V,, is end-systolic volume, E,, is the slope of the ESPVR, and V0 is the volume axis intercept of ESPVR. Diastolic properties were assessed by the end-diastolic pressure-volume relationship (EDPVR). The EDPVR was fit to a logarithmic function (12) as follows
where Ped is end-diastolic pressure, Ved is end-diastolic volume, S is normalized chamber stiffness, V, is the volume asymptote, and V, is the unstressed volume at which enddiastolic pressure equals zero. The parameters S, V,, and V, are all determined by nonlinear least-squares fitting algorithm applied to the measured Ped and Ved data. According to a previous study (12), V, corresponds to the hypothetical ventricular volume at which diastolic stiffness becomes infinitely large and represents the theoretically maximum volume that can be placed within the ventricular chamber. Assessment of myocardial systolic and diastolic properties. To assess average regional systolic and diastolic myocardial properties, a stress-strain analysis was performed. Myocardial fiber stress (a) and natural strain (E) were estimated by the following formulas (3), which assume a thick-walled rotationally symmetric chamber
where V, is LV wall volume, which was set equal to ventricular mass divided by an assumed specific gravity of 0.96 g/ml, LW is left ventricular volume, and LVP is left ventricular pressure.
To determine the degree to which the results obtained from this analysis were dependent on the geometric model, circumferential stress and strain were also estimated using a model that assumes thick-walled spheric chamber
where 
RESULTS
In Situ Ventricular Function
Coronary embolizations were completed within an average of 66 days, and animals were followed for an average of 286 days from the first embolization; thus the average observation period following completion of embolization was 220 days. The time course of EDA, ESA, and fractional area changes as a function of time after the first embolization are shown in Fig. 1 The third data point in each graph represents data collected just before killing the animals for the isolated heart study. Asterisks indicate significant differences from baseline values. The ESA after the last embolization was increased from baseline and remained elevated until death of the animal. The EDA showed a similar trend. As a result, fractional area change decreased from an average of 49% at baseline to 37% after the last embolization and then to 34% at the end of the observation period. Two dogs developed massive ascites, and another dog became cachexic. The other dogs did not show overt heart failure symptoms at rest. From these data, we concluded that repeated coronary embolization produced an irreversible and slightly progressive model of moderate CHF.
Body weights and ventricular masses of the embolized and normal control animals are shown in Table 1 .
Although baseline body weights were matched between the two groups, there was an increase in body weight over time in the embolization group most likely due to fluid collection (P < 0.05 by paired t-test). Postmortem right ventricular masses were the same in the two groups. Left ventricular mass tended to be increased in the embolized hearts, although this trend did not reach statistical significance (P = 0.12).
ESPVR and EDPVR
End-systolic and end-diastolic pressure-volume points from normal and embolized hearts are shown in Fig. 2 . Different symbols indicate data from different animals. The solid lines show the average ESPVRs and EDPVRs of each group. The ESPVRs and EDPVRs of the embolization group are shifted to the right compared with the normal group. These differences are illustrated more clearly in Fig. 3 , which shows the mean t SD results. The ESPVR of the embolization group was shifted to the right and had a shallower slope as shown by the solid lines in Fig. 3A (dotted and broken lines indicate +SD of the respective group). The average ESPVR -slope (E,,) and intercept (V,) values are shown in Table  2 ; multiple linear regression analysis indicated that the differences between groups in both of these values were statistically significant.
The average EDPVRs (Fig. 3B ) also revealed a rightward shift in the embolized group compared with normal, indicating dilation and structural remodeling of the LV chamber. This was shown to be statistically significant by the differences in calculated V, (referred to as the maximal attainable volume) and V, (the values; these strain values were obtained by interpolation of the exponential fits to data of individual hearts. The stress-strain relationships of the two groups were overlapping in both systole and diastole. To test whether this result was peculiar to one geometric model of calculating stresses and strains, a different model was also used for the calculations (Q. 4). The results of that analysis (shown in Fig. 5 ) also indicated that there was no detectable difference in stress-strain relations between normal and embolized hearts. The only difference in results obtained from the two models was that the absolute values of stresses were lower when calculated via the spherical model (Eq. 4). This implies that despite the marked reduction in global chamber sys-. tolic strength and remodeling of the chamber (Figs. l-3), average systolic and diastolic properties of embounstressed volume) between the groups (Table 2 ). In contrast, there was no difference in S, the index of global myocardial diastolic stiffness.
Stress-Strain Relations
Average (*SD) end-systolic and end-diastolic stressstrain relations calculated from the original pressurevolume data according to Eq. 3 are shown for the control and embolized hearts in Fig. 4 . Each point renresents the mean (-+SD) strain at specified stress lized myocardium in the chronic setting are comparable to those from the normal group. Two other findings support this notion: 1) E,, normalized to LV mass (E,, *, Table 2 ), which provides a rough index of myocardial systolic properties, was comparable in the two groups; and 2) as noted above, the index of global myocardial diastolic stiffness (S, Table 2 ) was also not different between normal and embolized hearts.
P-Adrenergic Responsiveness
To test another aspect of myocardial properties known to be altered in heart failure, the dose of intracoronary isoproterenol necessary to induce an -20% increase in peak isovolumic LV pressure (at a fixed end-diastolic pressure of -10 mmHg) was determined. Results, summarized in Fig. 6 , reveal that embolized hearts exhibited a blunted inotropic response to isoproterenol compared with normal hearts (P = 0.06 by analysis of covariance). [isoproterenol] (rig/ml) 
Myocardial Energetics
Average (*SD) MVo,-PVA relations obtained from the six embolized and six body weight-matched control hearts are shown in Fig. 7 and summarized quantitatively in Table 2 ; note that MVO~ in Fig. 7 is normalized to LV mass in the conventional manner. The relationship for the embolization group was shifted downward in a parallel manner; there was no change in the slope (A, Table 2), but there was a decrease in the MVO, axis intercept (P < 0.05 by multiple linear regression analysis). The MVO, axis intercept represents MVO, in the mechanically unloaded state normalized to LV mass (B, Table 2 ). However, if we compare the absolute nonnormalized values of the MVO, axis-intercept (Babs, Table  2> , there was no difference between normal and embolized hearts (see DISCUSSION) .
Histology
An example of a digitized histological sample in which originally blue-stained pixels (collagen fibers) are shown in dark black is illustrated in Fig. 8 , which shows a typical multifocal pattern of scarring due to the microembolization.
The average collagen fractions determined by digital analysis of such images were 7.7 t 4.1, 7.2 2 3.7, and 8.8 t 5.3% at base, mid, and apical levels of the LV, respectively, with the overall average of 7.8 t 4.3%. Because microspheres tended to flow into the apical portion, that region had the largest collagen fraction.
DISCUSSION
Repeated coronary embolization resulted in sustained left ventricular dysfunction as evidenced by chamber enlargement and decreased wall motion detected by echocardiography in vivo which is consistent with previous reports (15, 16) . The degree of ventricular dysfunction was moderate (final fractional area change of 34%). When studied in isolation, chamber dilation was confirmed by direct measurement of diastolic pressure-volume relations, and chamber contractile dysfunction was confirmed by measurement of systolic pressure-volume relations. Heart mass tended to be increased compared with normal, consistent with observations of other investigators (1, 13, 161, suggesting that the surviving myocytes had increased their mass (compensatory hypertrophy).
The relative contributions of chamber dilation (remodeling) and muscle dysfunction to chamber contractile dysfunction were examined by performing a stress-strain analysis. This revealed that both the systolic and diastolic stressstrain relations of the ventricular wall in embolized hearts were not significantly different from those of normal control hearts. These findings were confirmed by two different commonly used forms of stress-strain analysis, suggesting that the findings are not peculiar to one formulation. Consistent with this, E,, values normalized to ventricular mass and a geometry-independent diastolic chamber stiffness S were both similar in normal and embolized hearts. Original expectations were that systolic wall stress would be depressed in the embolized animals because of the sustained and significant decrease in global ventricular performance detected both in situ and in vitro. The data suggest that in this model, global ventricular chamber contractile dysfunction is largely due to the chamber dilation (remodeling) but that hypertrophy in the surviving myocardium is adequate to normalize myocardial mass and that contractile function of the surviving hypertrophied myocardium is largely normal.
It was previously shown for the rapid pacing-induced heart failure model using stress-strain analysis that myocardial systolic properties are depressed (21). However, detailed examinations of those original data indicate that the differences in stress-strain relations between normal and heart failure animals are small compared with the large difference noted in the pressure-volume relations. This suggests that even in that model of severe heart failure it is difficult to document a significant reduction in myocardial contractile function despite overt chamber contractile dysfunction.
The finding of an unaltered diastolic stress-strain relationship was at first surprising in view of the scar tissue in infarcts throughout the myocardium of embolized hearts. It was expected that the diastolic stressstrain relationship would be elevated and that the myocardial stiffness parameter would be increased in embolized hearts compared with normal, reflecting the presence of stiff (scar) elements. This would certainly be the case if a region of the heart were acutely rendered noncontractile and stiff; however, the situation is different in the chronic setting where chamber remodeling and changes in properties of surviving muscles have occurred (15, 16). To explore how the stress-strain relationship may be affected by the introduction of stiff scar in the setting of ventricular remodeling, we performed a theoretical analysis that is summarized in the APPENDIX.
The results of that analysis indicated that (subject to the assumptions detailed in the APPENDIX), for the case of a chronically remodeled heart in which the surviving muscle undergoes compensatory hypertrophy (1,13), there is very little impact on either the systolic or diastolic stress-strain relationships even with marked changes in the composition of the myocardial wall. While based on theory and not direct observation, this analysis does provide a plausible explanation for the findings of the present study.
Observation in embolized hearts of an average of 7.8% (ranging up to 20%) is slightly smaller than the 12-21% noted by Sabbah et al. (16) . This may be due in part to the fact that we calculated the percent of collagen fraction using a computer-based digital processing technique that generates an index of scar area based on the sum of pixels that have met our stringent color criteria. Our method, as compared with that used by Sabbah et al. (16) , therefore most likely provides a more conservative estimate of scarring since the previous technique simply encircles areas stained by hand and may also include in its final estimation of degree of fibrosis speckled nonstained regions within the samples. Moreover, we waited for a longer time period (an average of 6 mo vs. the 3 mo in the Sabbah study) after the last ischemic insult; during that period, it is likely that the scars contracted further in the process of healing. Therefore, a greater amount of myocardium than the measured percent of scar must have been destroyed initially.
In addition, Whittaker et al. (19a) reported that Masson trichrome staining per se underestimated the amount of collagen compared with picroSirius red staining, which is regarded as a more accurate method for that purpose.
Although the baseline myocardial mechanical properties as assessed by stress-strain analysis were not found to be altered in this model, responsiveness to P-adrenergic stimulation was blunted as shown in Fig.  6 . This is consistent with what was found in the heart failure state in other animal models (11, 21) as well as in heart failure patients (5). Thus there is pharmacologi- Table 2 ). However, it is difficult to conclude whether this reflects a true change in energetics. This is because for these scarred hearts, MVO, normalized to total LV mass would be lower than MVO, normalized to LV myocardial mass; myocardial mass is the pertinent denominator for normalization because it is the myocytes that consume oxygen and not the scar tissue. An average 8% of collagen fraction, which may have underestimated scar content as detailed above, may account for a considerable part of the 25% difference in B noted between the two groups. In this regard, it is of interest to note that there was no difference between the MVO,-PVA intercepts from the two groups of hearts when these values were not normalized to LV mass (Babs values, Table 2 ). Still, we cannot exclude the possibility that there is a fundamental change in energetics in these embolized hearts. A previous study of repeatedly embolized dog hearts revealed dramatic changes in mitochondrial structural appearance (15), suggesting that there may be an alteration in metabolic properties in this form of heart failure. However, a functional analysis of changes in metabolic capacity has not been performed.
In addition, it is also of interest to note that these energetics results contrast with data from the rapid pacing heart failure model, which showed no change in intercept but a significant decrease in slope of the MVo,-PVA relationship (2 1). This difference in findings may be due to the differences in etiology of heart failure as well as differences in the degree of heart failure.
Limitations
As stated above, the degree of left ventricular dysfunction achieved using the present methods was most likely not as severe as in the rapid pacing model of heart failure or as in patients with end-stage heart failure. It is of note that previous studies with this model have shown more severe reductions in global volume ejection fraction (16). This may reflect differences in embolization techniques between the different groups of investigators. Alternatively, this may reflect differences in techniques used to evaluate ventricular function; that is, results obtained with the use of echocardiography in the conscious state (present study) may differ from results obtained using ventriculography under anesthesia (previous studies). Furthermore, because the echocardiographic technique only evaluated the wall motion at mid LV level, we may not have taken into account dysfunction at other areas of the heart. In fact, our ejection fraction by ventriculography measured under anesthesia before the last embolization was 28 t 3%. When we take into consideration that the fractional area change by echocardiography decreased after the last embolization, the ejection fraction value by ventriculography must have also decreased from this value. Neve?theless, the present results may not apply to the case of severe heart failure and should not be extrapolated to that condition. In particular, a small reduction in systolic stress-strain relations could be observed in severe heart failure, as has already been suggested for the pacing-induced heart failure model (21).
The main results of this study are observational in nature and are derived from direct measurements of pressure-volume relationships. However, one of the ancillary conclusions is based on the results of stressstrain analysis. Because this is a derived entity and not measured directly, it is important to explore the sensitivity and specificity of the analysis. As noted previously (3, 8, 22>, there are many mathematical schemes used to calculate stress and strain. It has been shown, however, that while absolute v alues for these parameters may differ between the various schemes, the relative changes in parameter values are typically not affected and, accordingly, the qualitative conclusions made from the data are not different (22) . As an example of this, we showed in the present data set, that the qualitative conclusions were the same using two very different means of determining stresses and strains despite marked differences in quantitative aspects of the results. Another limitation of stress-strain analysis is that it provides an assessment of average material properties which, in the case of the embolized heart, represent a composite of contracting myocardium and scar. To the extent that the scar tissue is much stiffer than the surviving myocardium, it is possible to assess the impact of the presence of scar on the results. As detailed above and in the APPENDIX, our analysis indicates that this does not introduce a major limitation in interpretation.
Furthermore, beta use scar tissu .e does not actively contract, conclusions pertaining to active force generation (and specifically end systole) are even The purpose of this analysis was to assess the effect of scar within the myocardial wall on stress-strain relationships in the chronic setting where both the ventricular chamber and the myocytes undergo structural remodeling.
Assume that the stress-strain ((J-E) relationship of normal myocardium is described by the following equation 
where L is muscle length, LO is the reference (unstressed) muscle length, and x is amount of muscle extension beyond the unstressed length (x = L -Lo). By substitution (T = a(x/L, + l)b + c
For the case of infarct, there is loss of muscle mass which is replaced with scar. Over time, the surviving muscle hypertrophies and elongates (1, 13). The expected effects of these processes are a normalization of total myocardial mass (Table  1) and an increase in LV unstressed volume (Table 2 ). In accordance with these experimental observations, we make the following assumptions: 1) that the properties of the surviving muscle are normal (Eq. Al), 2) that the hypertrophic response exactly balances the loss of muscle mass due to infarction, and 3) that the scar is a rigid element. On the basis of these assumptions, the net effect on the composite myocardium (normal myocardium plus scar) is to increase LO by an amount related to the amount of myocardium that was infarcted; that is, Lo for the chronic state (Lo,,) will be increased to CYLO, where CY is a scaling factor equal to the sum of one plus the percent of the myocardium that is scarred. In such a case, the relationship between myocardial stress and displacement (x in Eq. AZ) would be the same as in normal muscle (since the scar is considered to be a rigid element). However, strain in this chronic setting (E,) would now be calculated as follows % = In (L/L, ,) = In (LIaLO) = In (x/cxL, + 1)
By substitution, this can be simplified to the following 0 = a[a(e'c -1) + llh + c (A5) Figure 9 shows systolic (A) and diastolic (B) stress-strain relations using values for a, b, and c taken from a representative normal heart (solid lines) for both systole and diastole. To simulate a chronic state, cx was set at a value of 1.2 based on our and previous findings showing that, in the chronic state, a maximum 20% of the ventricular wall is composed of scar in this model (16). The predicted stress-strain relations for this case, shown by the dashed lines, revealed a rather small upward shift of both diastolic and systolic stress-strain relationships.
The predicted change in the relationship is smaller than the interanimal variability normally observed in these measurements (Fig. 4) . Furthermore, two factors suggest that the prediction provided by this analysis will overestimate the differences between normal and diseased state: 1) scar tissue has some elasticity and is not truly rigid, and 2) the percent of scar chosen for the simulation (20%) represents an upper bound on what has been observed in this model. Thus, subject to the assumptions of the analysis, the average stress-strain relationship of the chronically embolized, remodeled myocardium may not differ substantially from normal, despite the marked changes in composition of the ventricular wall.
